The kinase inhibitor Palbociclib is a potent and specific RNA-binding molecule
Shortridge, M. D.; Vidalala, V.; Varani, G.
Show abstract
The growing awareness of the role of RNA in human disease has motivated significant efforts to discover drug-like small molecules that target RNA. However, high throughput screening campaigns report very low hit rates and generally identify compounds with weak affinity, while most structures reported in Academic studies also lack the pharmacological properties of successful drugs. Even FDA-approved RNA-targeting drugs have only weak (10 M) binding activity. Thus, it is often stated that only complex RNA structures, such as the ribosome or riboswitches, are amenable to small molecule chemistry. We report that the kinase inhibitor Palbociclib/Ibrance is a nM ligand for the HIV-1 TAR. It inhibits recruitment of the positive transcription elongation factor complex at nM concentrations and discriminates >20 fold. We further show that RNA binding can be fully decoupled from kinase inhibition, yielding a new molecule with even higher affinity for RNA. We thus demonstrate that nM affinity, specificity, and potent biochemical activity against undruggable RNAs can be found in the chemical space of blockbuster drugs.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Small Molecule Targeting IRES Domain Inhibits Enterovirus 71 Replication via an Allosteric Mechanism that Stabilizes a Ternary Complex 96%
- Mechanistic Analysis of Riboswitch Ligand Interactions Provides Insights into Pharmacological Control over Gene Expression 96%
- The mechanism of the nucleo-sugar selection by multi-subunit RNA polymerases 94%
Similar papers in this journal
Similar papers in this journal
- Using a function-first "scout fragment"-based approach to develop allosteric covalent inhibitors of conformationally dynamic helicase mechanoenzymes 96%
- TRPM8 protein dynamics correlates with ligand structure and cellular function 94%
- Site-Specific Synthesis of N4-Acetylcytidine in RNA Reveals Physiological Duplex Stabilization 94%
Similar papers in this journal
- Design of an orally bioavailable small molecule that modulates the microtubule-associated protein tau's pre-mRNA splicing 96%
- R-BIND 2.0: An Updated Database of Bioactive RNA-Targeting Small Molecules and Associated RNA Secondary Structures 94%
- Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability 94%
Similar papers in this journal
- Machine learning-augmented molecular dynamics simulations (MD) reveal insights into the disconnect between affinity and activation of ZTPriboswitch ligands 95%
- An A-T Hoogsteen base pair in a naked DNA hairpin motif: A Protein-Recognized Conformation 94%
- Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.